327 related articles for article (PubMed ID: 33516338)
1. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study.
Li X; Mukandavire C; Cucunubá ZM; Echeverria Londono S; Abbas K; Clapham HE; Jit M; Johnson HL; Papadopoulos T; Vynnycky E; Brisson M; Carter ED; Clark A; de Villiers MJ; Eilertson K; Ferrari MJ; Gamkrelidze I; Gaythorpe KAM; Grassly NC; Hallett TB; Hinsley W; Jackson ML; Jean K; Karachaliou A; Klepac P; Lessler J; Li X; Moore SM; Nayagam S; Nguyen DM; Razavi H; Razavi-Shearer D; Resch S; Sanderson C; Sweet S; Sy S; Tam Y; Tanvir H; Tran QM; Trotter CL; Truelove S; van Zandvoort K; Verguet S; Walker N; Winter A; Woodruff K; Ferguson NM; Garske T;
Lancet; 2021 Jan; 397(10272):398-408. PubMed ID: 33516338
[TBL] [Abstract][Full Text] [Related]
2. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance.
Lee LA; Franzel L; Atwell J; Datta SD; Friberg IK; Goldie SJ; Reef SE; Schwalbe N; Simons E; Strebel PM; Sweet S; Suraratdecha C; Tam Y; Vynnycky E; Walker N; Walker DG; Hansen PM
Vaccine; 2013 Apr; 31 Suppl 2():B61-72. PubMed ID: 23598494
[TBL] [Abstract][Full Text] [Related]
3. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020.
Ozawa S; Clark S; Portnoy A; Grewal S; Stack ML; Sinha A; Mirelman A; Franklin H; Friberg IK; Tam Y; Walker N; Clark A; Ferrari M; Suraratdecha C; Sweet S; Goldie SJ; Garske T; Li M; Hansen PM; Johnson HL; Walker D
Bull World Health Organ; 2017 Sep; 95(9):629-638. PubMed ID: 28867843
[TBL] [Abstract][Full Text] [Related]
4. Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.
Hartner AM; Li X; Echeverria-Londono S; Roth J; Abbas K; Auzenbergs M; de Villiers MJ; Ferrari MJ; Fraser K; Fu H; Hallett T; Hinsley W; Jit M; Karachaliou A; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Minh QT; Vynnycky E; Winter AK; Burrows H; Chen C; Clapham HE; Deshpande A; Hauryski S; Huber J; Jean K; Kim C; Kim JH; Koh J; Lopman BA; Pitzer VE; Tam Y; Lambach P; Sim SY; Woodruff K; Ferguson NM; Trotter CL; Gaythorpe KAM
Lancet Glob Health; 2024 Apr; 12(4):e563-e571. PubMed ID: 38485425
[TBL] [Abstract][Full Text] [Related]
5. Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030.
Carter A; Msemburi W; Sim SY; Gaythorpe KAM; Lambach P; Lindstrand A; Hutubessy R
Vaccine; 2023 Aug; ():. PubMed ID: 37537094
[TBL] [Abstract][Full Text] [Related]
6. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.
Toor J; Echeverria-Londono S; Li X; Abbas K; Carter ED; Clapham HE; Clark A; de Villiers MJ; Eilertson K; Ferrari M; Gamkrelidze I; Hallett TB; Hinsley WR; Hogan D; Huber JH; Jackson ML; Jean K; Jit M; Karachaliou A; Klepac P; Kraay A; Lessler J; Li X; Lopman BA; Mengistu T; Metcalf CJE; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Razavi H; Razavi-Shearer D; Resch S; Sanderson C; Sweet S; Tam Y; Tanvir H; Tran Minh Q; Trotter CL; Truelove SA; Vynnycky E; Walker N; Winter A; Woodruff K; Ferguson NM; Gaythorpe KA
Elife; 2021 Jul; 10():. PubMed ID: 34253291
[TBL] [Abstract][Full Text] [Related]
7. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
Abbas K; Procter SR; van Zandvoort K; Clark A; Funk S; Mengistu T; Hogan D; Dansereau E; Jit M; Flasche S;
Lancet Glob Health; 2020 Oct; 8(10):e1264-e1272. PubMed ID: 32687792
[TBL] [Abstract][Full Text] [Related]
8. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
[TBL] [Abstract][Full Text] [Related]
9. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.
Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC
Lancet Infect Dis; 2022 Sep; 22(9):1293-1302. PubMed ID: 35753318
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study.
Debellut F; Clark A; Pecenka C; Tate J; Baral R; Sanderson C; Parashar U; Atherly D
Lancet Glob Health; 2021 Jul; 9(7):e942-e956. PubMed ID: 33891885
[TBL] [Abstract][Full Text] [Related]
11. Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study.
Abbas KM; van Zandvoort K; Brisson M; Jit M
Lancet Glob Health; 2020 Apr; 8(4):e536-e544. PubMed ID: 32105613
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.
Bilcke J; Antillón M; Pieters Z; Kuylen E; Abboud L; Neuzil KM; Pollard AJ; Paltiel AD; Pitzer VE
Lancet Infect Dis; 2019 Jul; 19(7):728-739. PubMed ID: 31130329
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.
Jit M; Brisson M; Portnoy A; Hutubessy R
Lancet Glob Health; 2014 Jul; 2(7):e406-14. PubMed ID: 25103394
[TBL] [Abstract][Full Text] [Related]
14. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
15. The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.
Baral R; Li X; Willem L; Antillon M; Vilajeliu A; Jit M; Beutels P; Pecenka C
Vaccine; 2020 Jul; 38(33):5139-5147. PubMed ID: 32586761
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.
Atherly D; Dreibelbis R; Parashar UD; Levin C; Wecker J; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S28-38. PubMed ID: 19817610
[TBL] [Abstract][Full Text] [Related]
17. Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation.
Fu H; Abbas K; Malvolti S; Gregory C; Ko M; Amorij JP; Jit M
BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 37949503
[TBL] [Abstract][Full Text] [Related]
18. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
[TBL] [Abstract][Full Text] [Related]
19. Estimating national-level measles case-fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study.
Sbarra AN; Mosser JF; Jit M; Ferrari M; Ramshaw RE; O'Connor P; Krause LK; Rogowski ELB; Portnoy A
Lancet Glob Health; 2023 Apr; 11(4):e516-e524. PubMed ID: 36925172
[TBL] [Abstract][Full Text] [Related]
20. Global vaccine coverage and childhood survival estimates: 1990-2019.
Zhang H; Patenaude B; Zhang H; Jit M; Fang H
Bull World Health Organ; 2024 Apr; 102(4):276-287. PubMed ID: 38562199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
